SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

16.80p
   
  • Change Today:
      0.18p
  • 52 Week High: 26.10
  • 52 Week Low: 8.50
  • Currency: UK Pounds
  • Shares Issued: 258.78m
  • Volume: 1,260,075
  • Market Cap: £43.47m
  • Beta: 0.01

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
98.34% above the market average98.34% above the market average98.34% above the market average98.34% above the market average98.34% above the market average
93.33% above the sector average93.33% above the sector average93.33% above the sector average93.33% above the sector average93.33% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
69.69% above the market average69.69% above the market average69.69% above the market average69.69% above the market average69.69% above the market average
69.23% above the sector average69.23% above the sector average69.23% above the sector average69.23% above the sector average69.23% above the sector average
Price Book Ratio
94.34% below the market average94.34% below the market average94.34% below the market average94.34% below the market average94.34% below the market average
84.62% below the sector average84.62% below the sector average84.62% below the sector average84.62% below the sector average84.62% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
79.49% below the market average79.49% below the market average79.49% below the market average79.49% below the market average79.49% below the market average
47.83% below the sector average47.83% below the sector average47.83% below the sector average47.83% below the sector average47.83% below the sector average
Price Chg 3m
90.93% below the market average90.93% below the market average90.93% below the market average90.93% below the market average90.93% below the market average
86.96% below the sector average86.96% below the sector average86.96% below the sector average86.96% below the sector average86.96% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
63.36% below the market average63.36% below the market average63.36% below the market average63.36% below the market average63.36% below the market average
61.9% below the sector average61.9% below the sector average61.9% below the sector average61.9% below the sector average61.9% below the sector average
Momentum 20
62.92% below the market average62.92% below the market average62.92% below the market average62.92% below the market average62.92% below the market average
38.1% below the sector average38.1% below the sector average38.1% below the sector average38.1% below the sector average38.1% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
84.33% below the market average84.33% below the market average84.33% below the market average84.33% below the market average84.33% below the market average
43.75% below the sector average43.75% below the sector average43.75% below the sector average43.75% below the sector average43.75% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
62.89% below the market average62.89% below the market average62.89% below the market average62.89% below the market average62.89% below the market average
39.13% below the sector average39.13% below the sector average39.13% below the sector average39.13% below the sector average39.13% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
78.82% below the market average78.82% below the market average78.82% below the market average78.82% below the market average78.82% below the market average
43.75% below the sector average43.75% below the sector average43.75% below the sector average43.75% below the sector average43.75% below the sector average
Operating Profit Loss
65.17% below the market average65.17% below the market average65.17% below the market average65.17% below the market average65.17% below the market average
8.7% below the sector average8.7% below the sector average8.7% below the sector average8.7% below the sector average8.7% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
75.6% below the market average75.6% below the market average75.6% below the market average75.6% below the market average75.6% below the market average
58.14% below the sector average58.14% below the sector average58.14% below the sector average58.14% below the sector average58.14% below the sector average
Cash
61.85% below the market average61.85% below the market average61.85% below the market average61.85% below the market average61.85% below the market average
55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SBTX Market Data

Currency UK Pounds
Share Price 16.80p
Change Today 0.18p
% Change 1.05 %
52 Week High 26.10
52 Week Low 8.50
Volume 1,260,075
Shares Issued 258.78m
Market Cap £43.47m
Beta 0.01

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
70.51% below the market average70.51% below the market average70.51% below the market average70.51% below the market average70.51% below the market average
86.96% below the sector average86.96% below the sector average86.96% below the sector average86.96% below the sector average86.96% below the sector average
Price Trend
64.49% above the market average64.49% above the market average64.49% above the market average64.49% above the market average64.49% above the market average
78.26% above the sector average78.26% above the sector average78.26% above the sector average78.26% above the sector average78.26% above the sector average
Income Not Available
Growth
48.70% above the market average48.70% above the market average48.70% above the market average48.70% above the market average48.70% above the market average
61.29% above the sector average61.29% above the sector average61.29% above the sector average61.29% above the sector average61.29% above the sector average

SBTX Dividends

No dividends found

Trades for 27-Jun-2025

Time Volume / Share Price
16:35 4,100 @ 16.80p
16:35 4,100 @ 16.80p
16:24 2,936 @ 16.62p
16:16 5,600 @ 16.62p
16:02 25,000 @ 16.00p

SBTX Key Personnel

CEO Stuart Ashman
CFO Manprit Singh Randhawa

Top of Page